[HTML][HTML] Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized …
The purpose of this study was to assess the pharmacokinetic (PK) characteristics, clinical
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled …
H Bao, Y Lv, D Wang, J Xue, Z Yan - European Journal of Clinical …, 2016 - infona.pl
The purpose of this study was to assess the pharmacokinetic (PK) characteristics, clinical
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
[HTML][HTML] Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized …
H Bao, Y Lv, D Wang, J Xue, Z Yan - European Journal of Clinical …, 2017 - ncbi.nlm.nih.gov
The purpose of this study was to assess the pharmacokinetic (PK) characteristics, clinical
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled …
H Bao, Y Lv, D Wang, J Xue… - European Journal of …, 2017 - search.ebscohost.com
The purpose of this study was to assess the pharmacokinetic (PK) characteristics, clinical
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
[PDF][PDF] Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized …
H Bao, Y Lv, D Wang, J Xue, Z Yan - 2016 - cyberleninka.org
The purpose of this study was to assess the pharmacokinetic (PK) characteristics, clinical
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled …
H Bao, Y Lv, D Wang, J Xue, Z Yan - 2017 - cabidigitallibrary.org
The purpose of this study was to assess the pharmacokinetic (PK) characteristics, clinical
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled …
H Bao, Y Lv, D Wang, J Xue, Z Yan - European Journal of Clinical …, 2016 - europepmc.org
The purpose of this study was to assess the pharmacokinetic (PK) characteristics, clinical
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
[PDF][PDF] Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized …
H Bao, Y Lv, D Wang, J Xue, Z Yan - 2016 - d-nb.info
The purpose of this study was to assess the pharmacokinetic (PK) characteristics, clinical
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled …
H Bao, Y Lv, D Wang, J Xue, Z Yan - 2017 - pubmed.ncbi.nlm.nih.gov
The purpose of this study was to assess the pharmacokinetic (PK) characteristics, clinical
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled …
H Bao, Y Lv, D Wang, J Xue… - European Journal of …, 2017 - search.proquest.com
The purpose of this study was to assess the pharmacokinetic (PK) characteristics, clinical
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …
efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by …